HTAs and rare diseases: How to assess their cost-effectiveness

Research output: Contribution to journalArticle

Electronic versions

DOI

Original languageEnglish
Pages (from-to)161-165
JournalPharmaceuticals Policy and Law
Volume13
Issue number3-4
DOIs
Publication statusPublished - 1 Nov 2011
View graph of relations